Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Olmesartan medoxomil Related Compound A

Olmesartan medoxomil Related Compound A is listed in the pharmaceutical impurity collection under CAS 849206-43-5. Its represented structure has formula C24H24N6O2 and a calculated molecular weight of 428.50 g/mol.

2D chemical structure

N N N N N H N O O

Chemical identity

Catalog name
Olmesartan medoxomil Related Compound A
Common name
Olmesartan medoxomil Related Compound A
Chemical name
Not available
CAS
849206-43-5
SMILES
CCCc1nc2c(n1Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)OC2(C)C
InChI
InChI=1S/C24H24N6O2/c1-4-7-19-25-21-20(23(31)32-24(21,2)3)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13H,4,7,14H2,1-3H3,(H,26,27,28,29)
InChIKey
JUQNVWFXORBZQJ-UHFFFAOYSA-N
Associated API
olmesartan | Olmesartan medoxomil | Olmesartan Medoxomil

Record ID: A674e598b7a6f

Computed properties

C24H24N6O2 Molecular formula
428.496 g/molMolecular weight
428.1961 DaMonoisotopic exact mass
98.58 ŲTopological polar surface area
4.1365 Calculated LogP (Wildman–Crippen)
118.8152 cm³/molMolar refractivity (Wildman–Crippen)
6 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 6 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 6 12 18 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight428.49675.18
Calculated LogP (Wildman–Crippen)4.136580.17
Topological polar surface area98.5871.16
Hydrogen-bond acceptors675.83
Hydrogen-bond donors138.08
Rotatable bonds (strict)669.73

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC24H24N6O2dimensionless
Molecular weight428.496g/mol
Monoisotopic exact mass428.1961Da
Topological polar surface area98.58Ų
Calculated LogP (Wildman–Crippen)4.1365dimensionless
Molar refractivity (Wildman–Crippen)118.8152cm³/mol
Hydrogen-bond acceptors6count
Hydrogen-bond donors1count
Rotatable bonds (strict)6count
Heavy atoms32count
Heteroatoms8count
Rings5count
Aromatic rings4count
Aliphatic rings1count
Saturated rings0count
Aromatic heterocycles2count
Aliphatic heterocycles1count
Saturated heterocycles0count
Aromatic carbocycles2count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.2917fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area185.2037Ų
Valence electrons162count
Radical electrons0count
Bertz complexity1,272.5791index
Balaban J1.483index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Olmesartan medoxomil Related Compound A

Qualification and safety assessment of Olmesartan medoxomil Related Compound A

Explore toxicological qualification of Olmesartan medoxomil Related Compound A and ICH M7 mutagenic impurity assessment of Olmesartan medoxomil Related Compound A for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Olmesartan medoxomil Related Compound A and acceptable intake and limit justification for Olmesartan medoxomil Related Compound A. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Olmesartan medoxomil Related Compound A

Explore Altox services and software through the Altox Pharma-Hub.